Director's Dealing • Dec 22, 2016
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 5516S
PureTech Health PLC
22 December 2016
PDMR DEALING NOTIFICATION
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Joseph Bolen
2
Reason for the notification
a)
Position/status
Chief Scientific Officer
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
PureTech Health plc
b)
LEI
N/A
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
| An option over ordinary shares of one pence each in the capital of PureTech Health plc ("Ordinary Shares") |
Option over Ordinary Shares with ISIN GB00BY2Z0H74
b)
Nature of the transaction
Pursuant to the terms of his Employment Agreement dated October 19, 2016, on December 21, 2016 PureTech Health plc granted a share option to Joseph Bolen in respect of 309,344 Ordinary Shares.
The option will vest in the following manner: 25% to vest on October 19, 2017, and remaining 75% shall vest in equal semi-annual instalments over the three years following October 19, 2017; provided that the option holder continues to be employed by PureTech Health plc on each such vesting date.
The option has an exercise price of 117 pence per share.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| Nil | 309,344 |
d)
Aggregated information
| - | Aggregated volume |
| - | Price |
N/A
e)
Date of the transaction
2016 December 21
f)
Place of the transaction
Outside a trading venue
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLFLLLQLFXFBX
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.